1. Effects of novel antidiabetes agents on apoptotic processes in diabetes and malignancy: Implications for lowering tissue damage
   Habib Yaribeygi et al, 2019, Life Sciences CrossRef
2. GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control
   Takashi Nomiyama et al, 2016, Expert Review of Endocrinology & Metabolism CrossRef
3. GI Peptides, Energy Balance, and Cancer
   Debora S. Bruno et al, 2017 CrossRef
4. Everestmab, a novel long-acting GLP-1/anti GLP-1R nanobody fusion protein, exerts potent anti-diabetic effects
   Hongchao Pan et al, 2020, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
5. Expression of Hypoxia-Inducible Factors in Different Stages of Pancreatic Tumor Progression
   Jung Hwa Jung et al, 2020, Reports CrossRef
6. The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular
   Junyuan Deng et al, 2022, Front. Cell Dev. Biol. CrossRef
7. GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death
   Wu Li et al, 2024, Journal of Obstetrics and Gynaecology CrossRef
8. Effect of glucagon-like peptide-1 receptor agonists on prostate cancer: A review
   Xu Yu et al, 2024 CrossRef
9. Unlocking the Multifaceted Roles of GLP-1: Physiological Functions and Therapeutic Potential.
   Tohada M. AL-Noshokaty et al, 2025, Toxicology Reports CrossRef